Kenzie MacIsaac

Investor

About

Partner with over 13 years in drug discovery at the intersection of genetics, genomics and bioinformatics. Previously a Senior Director at Bristol Myers Squibb and led translational bioinformatics at Fog Pharma.

Colleagues at Cure Ventures

Albert J. Robichaud

Partner at Cure Ventures

Annie Mitsak

Partner at Cure Ventures

Bill Amsbaugh

CTO and Partner at Cure Ventures

Courtney Turner

Director of Finance at Cure Ventures

David Fallace

Managing Partner at Cure Ventures

Dr. Michael Aberman

Investor at Cure Ventures

Dr. Milenko Cicmil

Investor at Cure Ventures

Drew King

CFO and Partner at Cure Ventures